The Billion-Dollar Molecule: The Quest For The Perfect Drug-..
-
- 1x de R$ 174,30 sem juros
- 2x de R$ 87,15 sem juros
- 3x de R$ 58,10 sem juros
-
R$ 165,58
-
R$ 174,30
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing--atom by atom--both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS. You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
| ISBN | 9780671510572 |
| Autor(a) | Werth, Barry |
| Editora | Simon & Schuster |
| Ano de edição | 1995 |
| Acabamento | Brochura |
Produtos relacionados
-
Nanoparticulates As Drug Carrier-..R$ 2.805,40até 4x de R$ 701,35 sem jurosou R$ 2.665,13 via Pix -
Color Stories: Behind The Scenes Of America's Billion-Dollar Beauty Industry-..R$ 140,69até 2x de R$ 70,34 sem jurosou R$ 133,66 via Pix -
Cryptomania: Hype, Hope, And The Fall Of Ftx's Billion-Dollar Fintech Empire-..R$ 174,22até 3x de R$ 58,07 sem jurosou R$ 165,51 via Pix
-
Categorias
Conteúdo
Sobre a loja
Myre Livraria, sua livraria online especializada em importação e revenda de livros nacionais e internacionais. Oferecemos uma vasta seleção de materiais didáticos de alta qualidade para aprender inglês, espanhol, francês, alemão e muito mais. Aproveite preços competitivos e entrega rápida em todo o Brasil
Pague com
Selos
Myre Editora Ltda. - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2025
